AI GxP validation for regulated life sciences
Regulatory

Do You Need to Rename AI in Your SOPs and Validation Documents?

The short answer is no. The longer answer covers where the new terminology will reach you anyway, how to write documents that survive a vocabulary change, and why a global find-and-replace is the wrong reflex.

Cybroscape Technologies5 min read

Key takeaway

The short answer is no. The longer answer covers where the new terminology will reach you anyway, how to write documents that survive a vocabulary change, and why a global find-and-replace is the wrong reflex.

Somebody in your organisation has already asked whether the SOPs need updating. It is a reasonable question and the answer is no — but the reasoning matters, because the same question will come back every time vocabulary shifts.

The US executive order of 29 September 2026 tells federal agencies what words to use in their own non-statutory materials. It says nothing about what a private company calls anything in its quality system.

Why a find-and-replace is the wrong reflex

Renaming AI to SI across your document set would cost you, in exchange for nothing:

  • A change control per document, each needing assessment and approval.
  • A retraining obligation. Revise an SOP and the people who follow it generally need read-and-understood records against the new version.
  • A version history full of cosmetic revisions, which makes real changes harder to find later.
  • Inconsistency with everything else — your EU documentation, your vendor contracts, your GAMP references and your existing validation packages would all still say AI.

And you would be doing it for a term that is, by the order's own definition, a synonym.

The one change worth making

Add a single sentence to your AI governance policy or validation procedure, at its next scheduled revision rather than as an emergency change:

"US federal materials may use the terms 'Super Intelligence' and 'SI' for what this procedure calls artificial intelligence. The terms are equivalent for the purposes of this procedure."

That sentence does the whole job. It means a reader who encounters SI in an FDA document knows the procedure covers it, and it means an inspector asking about SI gets a document that plainly addresses the question.

Writing documents that survive vocabulary changes

The deeper lesson is worth taking, because this will not be the last relabelling.

  • Define your terms once, centrally. If "artificial intelligence" is defined in one policy and referenced everywhere else, a future change is one document, not forty.
  • Describe behaviour, not branding. A procedure that says "systems whose output is not fully determined by explicit rules" keeps working regardless of the label. One that says "AI tools" depends on a word staying in fashion.
  • Scope by risk and function, not by technology name. Your controls should attach to what the system decides and what happens if it is wrong — the basis of any sound GxP risk assessment.

If your document set would need forty changes to absorb one new synonym, that is worth knowing, and it is a finding about your documentation architecture rather than about this order.

Background in what the rename changes for GxP, and the training implications in updating SOPs and training for AI.

Where to go next

Explore Cybroscape GxP Copilot for AI-native validation, Cybroscape TraceDraft for source-traceable clinical documentation, or book a demo to see either on your own data.

Part of our guide to GxP software — categories, evaluation criteria and how the platforms compare.

One evidence baseValidation, data integrity, change control
FDAEMAMHRAPMDACDSCOHealth CanadaTGASwissmedic
Regulators differ in emphasis, not in what a defensible record is. One evidence base built to the strictest applicable expectation, with each regulator's specific points mapped onto it, avoids running a separate validation approach per market.
See it on your own systemBring a URS or a system. We run GxP Copilot against it live on the call.
update sops si terminologyrename ai in sopssi validation documentsterminology change quality systemgxp validation
FAQ

Frequently Asked Questions

Prefer to talk first? Chat with us on WhatsApp or book a call with an expert.

Do we have to rename AI to SI in our SOPs?

No. The executive order directs federal agencies on the words they use in their own non-statutory materials. It places no obligation on private companies, and the regulations you are audited against still say artificial intelligence.

What would a find-and-replace actually cost?

A change control per document with assessment and approval, a retraining obligation because revised SOPs generally need fresh read-and-understood records, a version history full of cosmetic revisions that hides real changes, and inconsistency with your EU documentation, vendor contracts and GAMP references.

What is the one change worth making?

A single sentence in your AI governance policy or validation procedure at its next scheduled revision: US federal materials may use 'Super Intelligence' and 'SI' for what this procedure calls artificial intelligence, and the terms are equivalent for the purposes of this procedure.

How do you write documents that survive vocabulary changes?

Define terms once centrally and reference that definition everywhere, so a future change is one document rather than forty. Describe behaviour rather than branding — 'systems whose output is not fully determined by explicit rules' outlives any label. And scope controls by risk and function rather than by technology name.

What if our documents would need dozens of changes?

That is worth knowing, and it is a finding about your documentation architecture rather than about this order. It means terms are defined in many places instead of one, which will cost you again at the next change.

Keep reading

All articles
RegulatoryWhat Is Super Intelligence (SI)? A Plain Definition for Regulated TeamsSuper Intelligence is now the US federal term for what everyone else still calls AI, and the order defines it as exactly that. What SI means, what it does not mean, and why the everyday sense of the word is not the legal one. · 5 min readRegulatoryAI Is Now "SI" in US Federal Language: What It Changes for GxPThe White House has directed federal agencies to say Super Intelligence instead of artificial intelligence. What the order actually does, what it explicitly does not touch, and what regulated companies should do about it, which is less than you might think. · 6 min readRegulatoryAfter the SI Rename: Everything About AI Validation That Has Not ChangedPart 11, Annex 11, the draft Annex 22, GAMP 5 and every validation obligation you had last week are untouched by a terminology order. A clear list of what still applies, and the one thing that genuinely might shift. · 5 min readRegulatoryStructured CMC data: managing the dossier as data, not documentsStructured CMC data manages specifications, processes and registrations as linked data instead of copies in documents, so you can see where any fact is registered and what a change affects. · 3 min readRegulatoryAI for regulatory intelligence: let it read, keep people decidingAI is good at monitoring regulatory publications, summarising and sorting them. Deciding what a change means for your products stays with people, and every summary should link to the source passage. · 3 min readRegulatoryAnnex 22 is being rewritten to allow generative AI: what EMA's workshop report saysEMA/156789/2026 records that the drafting group has discussed dropping the generative-AI exclusion in favour of a risk-based control strategy. What changed, what did not, and what to do now. · 10 min readRegulatoryCMC in Pharma: What Chemistry, Manufacturing, and Controls Means for Validation TeamsCMC is where drug development meets manufacturing reality. Here is what validation and quality teams need to understand about CMC requirements, and where validation fits in the CMC lifecycle. · 6 min readRegulatoryICH Q12 in practice: why uptake is slow and where it pays offICH Q12 lets companies agree established conditions with regulators and manage other changes in their own quality system. It pays off most for long-lived products with frequent changes, but needs strong, structured process data. · 3 min read

Bring a system. We'll show you the package.

Book a demo, or ask a validation lead a quick question on WhatsApp.

  • We reply within one business day
  • We run your URS live on the call
  • You get a clear plan for your system
Chat on WhatsApp

Book a demo

Four fields. The right specialist replies within one business day.

Your details stay private. We never share them.